GLP-1 Users Who Track May Lose Up to 45% More Weight Real-world data suggests greater weight loss among GLP-1 users who track injections and weight Theres something quietly powerful happening in the overlap between medication and mindfulness
Mounjaro has shown to be incredibly effective in lowering patient HbA1c levels, as well as being highly effective at facilitating weight loss
Oral semaglutide is taken once daily and reduces HbA 1c levels to a significantly higher extent than DPP-4 inhibition or sodiumglucose cotransporter 2 (SGLT-2) inhibition and to a similar extent as liraglutide, whereas body weight is reduced by a significantly higher extent than by DPP-4 inhibition and liraglutide and to a similar extent as SGLT-2 inhibition [30, 31]
Additionally, some individuals may experience side effects such as nausea or diarrhea
How can you control the short-term side effects, such as gastrointestinal symptoms and muscle loss (Ozempic face), and what are the long-term risks of taking these drugs
Clinical studies have demonstrated that short-acting GLP-1 RAs have a greater efficacy in lowering PPG level, while long-acting GLP-1 RAs predominantly affect FPG levels